Symbols / MRAI $0.28 +0.00% Marpai, Inc.

Healthcare • Healthcare Plans • United States • OQX
MRAI Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company offers third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also provides in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company offers health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Fundamentals
Scroll to Statements
Market Cap 7.08M Enterprise Value 34.59M Income -16.56M Sales 18.10M Book/sh -1.35 Cash/sh 0.01
Dividend Yield — Payout 0.00% Employees 107 IPO — P/E — Forward P/E -0.74
PEG — P/S 0.39 P/B -0.21 P/C — EV/EBITDA -2.71 EV/Sales 1.91
Quick Ratio 0.04 Current Ratio 0.40 Debt/Eq — LT Debt/Eq — EPS (ttm) -2.92 EPS next Y -0.38
EPS Growth — Revenue Growth -39.50% Earnings 2026-05-13 ROA -71.14% ROE — ROIC —
Gross Margin 26.41% Oper. Margin -123.04% Profit Margin -91.50% Shs Outstand 25.29M Shs Float 14.91M Short Float 0.24%
Short Ratio 0.11 Short Interest — 52W High 1.78 52W Low 0.21 Beta 4.82 Avg Volume 68.83K
Volume 509.00 Target Price — Recom None Prev Close $0.28 Price $0.28 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.28
Latest analyst target
3. DCF / Fair value
$-1.90
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.28
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-03-28 up Maxim Group Hold → Buy $6
2023-11-15 down Maxim Group Buy → Hold —
2023-11-14 down Maxim Group Buy → Hold —
News
RSS: Latest MRAI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-19 SHIV SAGIV Director — 100,000 $0.00 $0
2025-11-07 EITAN YARON I Director — 100,000 $1.42 $141,500
2025-11-07 PONS ROBERT M Director — 50,000 $1.42 $70,750
2025-11-07 SHIV SAGIV Director — 50,000 $1.42 $70,750
2025-11-07 SCRIP DALLAS Chief Operating Officer — 100,000 $1.42 $141,500
2025-10-20 EITAN YARON I Director — 125,000 $0.00 $0
2025-10-20 SHIV SAGIV Director — 75,000 $0.00 $0
2025-10-20 CALABRESE JENNIFER ROSARIO Director — 50,000 $0.00 $0
2025-10-20 LAMENDOLA DAMIEN Chief Executive Officer — 550,000 $0.00 $0
2025-10-20 JOHNSON STEVE ANDREW Chief Financial Officer — 275,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Revenue
37.16
+52.64%
24.34
+71.10%
14.23
Operating Revenue
37.16
+52.64%
24.34
+71.10%
14.23
Cost Of Revenue
24.24
+41.45%
17.14
+66.54%
10.29
Reconciled Cost Of Revenue
22.74
+37.49%
16.54
+62.30%
10.19
Gross Profit
12.92
+79.25%
7.21
+83.01%
3.94
Operating Expense
39.29
+15.93%
33.89
+71.17%
19.80
Research And Development
1.31
-64.63%
3.71
+113.85%
1.73
Selling General And Administration
25.77
+33.84%
19.26
+47.89%
13.02
Selling And Marketing Expense
6.60
-4.92%
6.94
+39.74%
4.97
General And Administrative Expense
19.18
+55.68%
12.32
+52.92%
8.06
Other Gand A
19.18
+55.68%
12.32
+52.92%
8.06
Other Operating Expenses
8.31
+12.47%
7.39
+139.64%
3.08
Total Expenses
63.53
+24.50%
51.03
+69.59%
30.09
Operating Income
-26.37
+1.16%
-26.68
-68.23%
-15.86
Total Operating Income As Reported
-27.98
-3.78%
-26.96
-69.95%
-15.86
EBITDA
-22.12
+2.08%
-22.59
-65.51%
-13.65
Normalized EBITDA
-20.49
+8.18%
-22.31
-63.73%
-13.63
Reconciled Depreciation
5.40
+30.49%
4.14
+100.65%
2.06
EBIT
-27.51
-2.96%
-26.72
-70.13%
-15.71
Total Unusual Items
-1.63
-495.54%
-0.27
-1346.95%
-0.02
Total Unusual Items Excluding Goodwill
-1.63
-495.54%
-0.27
-1346.95%
-0.02
Special Income Charges
-1.60
-486.65%
-0.27
0.00
Impairment Of Capital Assets
3.02
0.00
—
Net Income
-28.75
-8.63%
-26.47
-65.58%
-15.98
Pretax Income
-29.04
-7.60%
-26.99
-67.27%
-16.13
Net Non Operating Interest Income Expense
-1.53
-472.55%
-0.27
+37.55%
-0.43
Interest Expense Non Operating
1.53
+472.55%
0.27
-37.55%
0.43
Net Interest Income
-1.53
-472.55%
-0.27
+37.55%
-0.43
Interest Expense
1.53
+472.55%
0.27
-37.55%
0.43
Other Income Expense
-1.14
-2803.61%
-0.04
-125.60%
0.15
Other Non Operating Income Expenses
0.49
+108.50%
0.23
+35.92%
0.17
Gain On Sale Of Security
-0.03
-7233.80%
-0.00
+98.09%
-0.02
Gain On Sale Of Business
1.75
0.00
—
Tax Provision
-0.29
+44.33%
-0.52
-247.42%
-0.15
Tax Rate For Calcs
0.00
-47.37%
0.00
+111.11%
0.00
Tax Effect Of Unusual Items
-0.02
-213.44%
-0.01
-2954.66%
-0.00
Net Income Including Noncontrolling Interests
-28.75
-8.63%
-26.47
-65.58%
-15.98
Net Income From Continuing Operation Net Minority Interest
-28.75
-8.63%
-26.47
-65.58%
-15.98
Net Income From Continuing And Discontinued Operation
-28.75
-8.63%
-26.47
-65.58%
-15.98
Net Income Continuous Operations
-28.75
-8.63%
-26.47
-65.58%
-15.98
Normalized Income
-27.14
-3.58%
-26.20
-64.10%
-15.97
Net Income Common Stockholders
-28.75
-8.63%
-26.47
-65.58%
-15.98
Diluted EPS
-4.14
+20.99%
-5.24
+17.61%
-6.36
Basic EPS
-4.14
+20.99%
-5.24
+17.61%
-6.36
Basic Average Shares
6.95
+37.39%
5.06
+100.86%
2.52
Diluted Average Shares
6.95
+37.39%
5.06
+100.86%
2.52
Diluted NI Availto Com Stockholders
-28.75
-8.63%
-26.47
-65.58%
-15.98
Depreciation Amortization Depletion Income Statement
3.90
+10.13%
3.54
+80.36%
1.96
Depreciation And Amortization In Income Statement
3.90
+10.13%
3.54
+80.36%
1.96
Gain On Sale Of PPE
-0.34
-22.56%
-0.27
0.00
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Assets
31.68
-36.58%
49.95
+13.00%
44.20
Current Assets
17.08
-35.62%
26.54
-1.68%
26.99
Cash Cash Equivalents And Short Term Investments
1.15
-91.67%
13.76
-28.25%
19.18
Cash And Cash Equivalents
1.15
-91.67%
13.76
-28.25%
19.18
Receivables
2.70
+48.56%
1.82
+476.97%
0.32
Accounts Receivable
1.13
-21.74%
1.44
+588.72%
0.21
Gross Accounts Receivable
1.15
-21.32%
1.46
+599.96%
0.21
Allowance For Doubtful Accounts Receivable
-0.02
-4.94%
-0.02
0.00
Other Receivables
1.58
+313.85%
0.38
+257.85%
0.11
Prepaid Assets
—
—
0.74
Restricted Cash
12.34
+31.99%
9.35
+38.54%
6.75
Other Current Assets
0.89
-44.35%
1.60
+115.57%
0.74
Total Non Current Assets
14.59
-37.66%
23.41
+36.04%
17.21
Net PPE
2.98
-44.21%
5.35
+82.30%
2.93
Gross PPE
3.13
-47.74%
6.00
+85.73%
3.23
Accumulated Depreciation
-0.15
+76.78%
-0.65
-119.82%
-0.30
Properties
0.00
0.00
0.00
Machinery Furniture Equipment
0.62
-38.39%
1.01
+194.85%
0.34
Other Properties
2.51
-40.78%
4.24
+87.32%
2.27
Leases
0.00
-100.00%
0.75
+19.94%
0.62
Goodwill And Other Intangible Assets
10.32
-38.37%
16.75
+17.99%
14.20
Goodwill
3.02
-48.30%
5.84
+144.95%
2.38
Other Intangible Assets
7.30
-33.06%
10.91
-7.62%
11.81
Non Current Prepaid Assets
1.27
-2.05%
1.29
+2373.68%
0.05
Other Non Current Assets
0.02
+0.00%
0.02
-23.52%
0.03
Total Liabilities Net Minority Interest
45.12
+2.97%
43.82
+202.32%
14.49
Current Liabilities
20.84
+20.06%
17.36
+55.76%
11.15
Payables And Accrued Expenses
17.84
+24.49%
14.33
+72.65%
8.30
Payables
4.65
+218.22%
1.46
+29.33%
1.13
Accounts Payable
4.65
+218.92%
1.46
+29.47%
1.13
Current Accrued Expenses
13.19
+2.49%
12.87
+79.47%
7.17
Pensionand Other Post Retirement Benefit Plans Current
1.20
-16.13%
1.43
+59.74%
0.90
Current Debt And Capital Lease Obligation
0.51
-60.92%
1.31
+67.15%
0.78
Current Capital Lease Obligation
0.51
-60.92%
1.31
+67.15%
0.78
Current Deferred Liabilities
0.66
+129.06%
0.29
-75.24%
1.17
Current Deferred Revenue
0.66
+129.06%
0.29
-75.24%
1.17
Other Current Liabilities
0.63
+158.82%
0.24
-41.76%
0.42
Total Non Current Liabilities Net Minority Interest
24.27
-8.24%
26.46
+690.22%
3.35
Long Term Debt And Capital Lease Obligation
3.68
-22.80%
4.77
+266.55%
1.30
Long Term Capital Lease Obligation
3.68
-22.80%
4.77
+266.55%
1.30
Non Current Deferred Liabilities
1.19
-19.61%
1.48
-26.04%
2.00
Non Current Deferred Taxes Liabilities
1.19
-19.61%
1.48
-26.04%
2.00
Other Non Current Liabilities
19.40
-3.97%
20.20
+44797.11%
0.04
Stockholders Equity
-13.44
-319.07%
6.13
-79.35%
29.71
Common Stock Equity
-13.44
-319.07%
6.13
-79.35%
29.71
Capital Stock
0.00
+49.62%
0.00
-73.79%
0.00
Common Stock
0.00
+49.62%
0.00
-73.79%
0.00
Share Issued
7.96
+49.65%
5.32
+4.82%
5.07
Ordinary Shares Number
7.96
+49.65%
5.32
+4.82%
5.07
Additional Paid In Capital
63.31
+16.96%
54.13
+5.65%
51.23
Retained Earnings
-76.75
-59.91%
-47.99
-122.96%
-21.53
Total Equity Gross Minority Interest
-13.44
-319.07%
6.13
-79.35%
29.71
Total Capitalization
-13.44
-319.07%
6.13
-79.35%
29.71
Working Capital
-3.76
-140.94%
9.18
-42.08%
15.85
Invested Capital
-13.44
-319.07%
6.13
-79.35%
29.71
Total Debt
4.20
-31.02%
6.08
+191.57%
2.09
Capital Lease Obligations
4.20
-31.02%
6.08
+191.57%
2.09
Net Tangible Assets
-23.76
-123.85%
-10.61
-168.42%
15.51
Tangible Book Value
-23.76
-123.85%
-10.61
-168.42%
15.51
Dueto Related Parties Current
0.00
-100.00%
0.00
-11.99%
0.00
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-15.75
+55.31%
-35.24
-226.43%
-10.80
Cash Flow From Continuing Operating Activities
-15.75
+55.31%
-35.24
-226.43%
-10.80
Net Income From Continuing Operations
-28.75
-8.63%
-26.47
-65.58%
-15.98
Depreciation Amortization Depletion
5.40
+30.49%
4.14
+100.65%
2.06
Depreciation
1.84
+84.89%
1.00
-51.68%
2.06
Amortization Cash Flow
3.56
+13.23%
3.14
—
Depreciation And Amortization
5.40
+30.49%
4.14
+100.65%
2.06
Amortization Of Intangibles
3.56
+13.23%
3.14
—
Other Non Cash Items
1.61
+440.19%
0.30
-36.40%
0.47
Stock Based Compensation
2.10
-32.42%
3.11
+152.31%
1.23
Asset Impairment Charge
3.02
0.00
—
Deferred Tax
-0.29
+44.33%
-0.52
-247.42%
-0.15
Deferred Income Tax
-0.29
+44.33%
-0.52
-247.42%
-0.15
Operating Gains Losses
-1.17
-528.62%
0.27
—
Gain Loss On Investment Securities
0.24
—
—
Change In Working Capital
2.34
+114.59%
-16.06
-1117.11%
1.58
Change In Receivables
-0.08
+84.48%
-0.54
-336.03%
-0.12
Changes In Account Receivables
-0.11
+82.35%
-0.60
-354.00%
-0.13
Change In Prepaid Assets
0.74
-17.44%
0.89
+357.29%
-0.35
Change In Payables And Accrued Expense
3.24
+122.04%
-14.70
-762.80%
2.22
Change In Accrued Expense
0.05
+100.35%
-14.88
-711.66%
2.43
Change In Payable
3.19
+1684.67%
0.18
+183.24%
-0.21
Change In Account Payable
3.19
+1658.84%
0.18
+614.17%
0.03
Change In Other Current Assets
0.00
-100.00%
0.01
+123.53%
-0.03
Change In Other Current Liabilities
-1.55
+10.40%
-1.73
-1136.61%
-0.14
Investing Cash Flow
1.03
-96.83%
32.42
+236.20%
9.64
Cash Flow From Continuing Investing Activities
1.03
-96.83%
32.42
+236.20%
9.64
Net PPE Purchase And Sale
0.03
+107.42%
-0.36
-32.67%
-0.27
Purchase Of PPE
0.00
+100.00%
-0.36
-32.67%
-0.27
Sale Of PPE
0.03
0.00
0.00
Capital Expenditure
—
-0.97
+44.52%
-1.74
Capital Expenditure Reported
0.00
+100.00%
-0.60
+58.82%
-1.46
Net Business Purchase And Sale
1.00
0.00
—
Gain Loss On Sale Of Business
-1.75
0.00
—
Net Intangibles Purchase And Sale
—
0.00
+100.00%
-0.00
Purchase Of Intangibles
—
0.00
+100.00%
-0.00
Net Other Investing Changes
—
33.39
+193.29%
11.38
Financing Cash Flow
5.10
+2600186.73%
0.00
-100.00%
25.27
Cash Flow From Continuing Financing Activities
5.10
+2600186.73%
0.00
-100.00%
25.27
Net Issuance Payments Of Debt
—
0.00
+100.00%
-0.23
Issuance Of Debt
—
0.00
-100.00%
3.55
Repayment Of Debt
—
0.00
+100.00%
-3.78
Long Term Debt Issuance
—
0.00
-100.00%
0.55
Long Term Debt Payments
—
0.00
+100.00%
-0.78
Net Long Term Debt Issuance
—
0.00
+100.00%
-0.23
Short Term Debt Issuance
—
0.00
-100.00%
3.00
Short Term Debt Payments
—
0.00
+100.00%
-3.00
Net Short Term Debt Issuance
—
0.00
0.00
Net Common Stock Issuance
6.73
0.00
-100.00%
25.38
Proceeds From Stock Option Exercised
0.03
+16541.84%
0.00
-99.98%
0.95
Net Other Financing Charges
-1.66
—
-0.83
Changes In Cash
-9.63
-241.76%
-2.82
-111.68%
24.12
Beginning Cash Position
23.12
-10.86%
25.93
+1326.55%
1.82
End Cash Position
13.49
-41.64%
23.12
-10.86%
25.93
Free Cash Flow
-15.75
+56.50%
-36.20
-188.82%
-12.54
Common Stock Issuance
6.73
0.00
-100.00%
25.38
Issuance Of Capital Stock
6.73
0.00
-100.00%
25.38
Sale Of Business
1.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category